Status:

UNKNOWN

Erythropoietin in Acute Myocardial Infarction

Lead Sponsor:

Hammersmith Hospitals NHS Trust

Conditions:

Acute Myocardial Infarction

Eligibility:

All Genders

18-80 years

Phase:

PHASE2

Brief Summary

Erythropoietin (EPO) is a naturally occuring hormone which regulates the body's response to lack of oxygen and controls the number of red cells in the blood. Recent studies in animals have shown that ...

Detailed Description

We wish to perform a randomised double-blind, placebo-controlled clinical trial to examine the effects of EPO given at the time of primary angioplasty for acute myocardial infarction (MI) on myocardia...

Eligibility Criteria

Inclusion

  • Male or female \>18 years of age
  • Weight between 50 kg and 120 kg
  • Suspected of having his/her first-documented STEMI
  • Symptoms of ischemia of \>20 min with \< 6h prior to PCI
  • Either 1mm ST elevation in at least two contiguous limb leads or \>2mm ST elevation in 2 contiguous chest leads
  • Primary PCI to occur within 8h from the onset of symptoms
  • Women of childbearing potential must have a negative pregnancy test

Exclusion

  • Contraindications to MRI scanning
  • History or ECG evidence of previous STEMI
  • Cardiogenic shock
  • NYHA class III-IV heart failure
  • LBBB or AF on ECG; 6.Major trauma, major surgery, eye, spinal cord, or brain surgery within the last 3 months
  • Significant hepatic disturbance
  • Chronic renal impairment (Creatinine \>200µmol/L)
  • Stroke or TIA \<6 months
  • Pregnancy or breast-feeding
  • Dependence on alcohol or other DOA
  • Significant psychiatric/neurologic disease that would prevent adherence to the requirements of the protocol
  • Significant immunocompromise (including, but not limited to AIDS and immune-suppressive therapy
  • Current treatment with human recombinant erythropoietin
  • Current hemodialysis or peritoneal dialysis

Key Trial Info

Start Date :

October 1 2005

Trial Type :

INTERVENTIONAL

End Date :

January 1 2008

Estimated Enrollment :

124 Patients enrolled

Trial Details

Trial ID

NCT00149058

Start Date

October 1 2005

End Date

January 1 2008

Last Update

September 8 2005

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Hammersmith Hospital NHS Trust

London, United Kingdom, W12 0HS

2

King's College London

London, United Kingdom, W12 0HS